Compare Elder Pharma with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs ABBOTT INDIA - Comparison Results

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA ABBOTT INDIA ELDER PHARMA/
ABBOTT INDIA
 
P/E (TTM) x -0.2 48.2 - View Chart
P/BV x 0.1 13.8 0.7% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 ELDER PHARMA   ABBOTT INDIA
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
ABBOTT INDIA
Mar-18
ELDER PHARMA/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs3806,110 6.2%   
Low Rs1883,996 4.7%   
Sales per share (Unadj.) Rs491.21,552.2 31.6%  
Earnings per share (Unadj.) Rs-3.2188.8 -1.7%  
Cash flow per share (Unadj.) Rs14.4196.4 7.3%  
Dividends per share (Unadj.) Rs055.00 0.0%  
Dividend yield (eoy) %01.1 0.0%  
Book value per share (Unadj.) Rs376.5796.6 47.3%  
Shares outstanding (eoy) m20.5421.25 96.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.63.3 17.8%   
Avg P/E ratio x-89.326.8 -333.5%  
P/CF ratio (eoy) x19.725.7 76.6%  
Price / Book Value ratio x0.86.3 11.9%  
Dividend payout %029.1 0.0%   
Avg Mkt Cap Rs m5,833107,376 5.4%   
No. of employees `000NA3.3 0.0%   
Total wages/salary Rs m2,1793,937 55.3%   
Avg. sales/employee Rs ThNM9,929.3-  
Avg. wages/employee Rs ThNM1,185.1-  
Avg. net profit/employee Rs ThNM1,207.7-  
INCOME DATA
Net Sales Rs m10,08932,985 30.6%  
Other income Rs m2571,170 21.9%   
Total revenues Rs m10,34634,155 30.3%   
Gross profit Rs m-7925,245 -15.1%  
Depreciation Rs m361162 223.2%   
Interest Rs m2,75638 7,215.4%   
Profit before tax Rs m-3,6536,215 -58.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m1252,203 5.7%   
Profit after tax Rs m-654,012 -1.6%  
Gross profit margin %-7.815.9 -49.4%  
Effective tax rate %-3.435.4 -9.7%   
Net profit margin %-0.612.2 -5.3%  
BALANCE SHEET DATA
Current assets Rs m9,24022,655 40.8%   
Current liabilities Rs m9,9986,681 149.6%   
Net working cap to sales %-7.548.4 -15.5%  
Current ratio x0.93.4 27.3%  
Inventory Days Days4665 71.5%  
Debtors Days Days6029 205.6%  
Net fixed assets Rs m10,124835 1,211.7%   
Share capital Rs m206213 96.8%   
"Free" reserves Rs m5,58216,715 33.4%   
Net worth Rs m7,73416,928 45.7%   
Long term debt Rs m4,8890-   
Total assets Rs m22,88224,162 94.7%  
Interest coverage x-0.3163.7 -0.2%   
Debt to equity ratio x0.60-  
Sales to assets ratio x0.41.4 32.3%   
Return on assets %11.816.8 70.2%  
Return on equity %-0.823.7 -3.6%  
Return on capital %22.336.9 60.4%  
Exports to sales %3.00-   
Imports to sales %0.40-   
Exports (fob) Rs m307NA-   
Imports (cif) Rs m43NA-   
Fx inflow Rs m307369 83.2%   
Fx outflow Rs m1253,807 3.3%   
Net fx Rs m181-3,438 -5.3%   
CASH FLOW
From Operations Rs m11,7541,527 769.8%  
From Investments Rs m-561-2,148 26.1%  
From Financial Activity Rs m-6,762-1,024 660.1%  
Net Cashflow Rs m4,432-1,646 -269.3%  

Share Holding

Indian Promoters % 39.6 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 7.5 7.9 94.9%  
FIIs % 16.8 0.1 16,800.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 17.1 211.1%  
Shareholders   16,479 18,270 90.2%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   SUVEN LIFESCIENCES  SHASUN PHARMA  PFIZER  TTK HEALTHCARE  SUN PHARMA  

Compare ELDER PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 87 Points Higher; Telecom and Auto Stocks Witness Buying(Closing)

Indian share markets ended their trading session marginally higher. On the sectoral front, gains were seen in the telecom sector and auto sector.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (2QFY19); Net Profit Up 0.1% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 0.1% YoY). Sales on the other hand came in at Rs 10 bn (up 5.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY19); Net Profit Up 70.8% (Quarterly Result Update)

Aug 20, 2018 | Updated on Aug 20, 2018

For the quarter ended June 2018, ABBOTT INDIA has posted a net profit of Rs 824 m (up 70.8% YoY). Sales on the other hand came in at Rs 8 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

What if Indiabulls Housing Finance and Yes Bank Do Not Rebound?(Profit Hunter)

Oct 1, 2019

How long should you wait for fallen blue chips like Yes Bank and Indiabulls Housing Finance to rebound?

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA 8-QTR ANALYSIS

COMPARE ELDER PHARMA WITH

MARKET STATS